In this month’s The Regueiro Report, I’d like to highlight two exciting FDA approvals for moderately to severely active ulcerative…
Browsing: Ulcerative Colitis
JAK inhibitors, particularly AbbVie’s Rinvoq, are gaining significant traction in both early and later line treatments for ulcerative colitis in…
In November 2023, the field of gastroenterology saw several notable developments: These developments in gastroenterology reflect ongoing efforts to improve…